EMBLA MEDICAL HF. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.2 DKK | 0.00% |
|
-5.19% | +6.38% |
| 04-23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
| 04-23 | Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Embla Medical hf.
6a619a1c8ccb4.TJSNNwcOUSzuTWQSERCzeR8LvuZOExu-FEAZ_bzjzz8.HdPJZFFgGlrYNQBWaWH8SW9I6tIrcGz1fHgsicWNuXkD4cNeQkASGKI5Fw~a6b4d6ee0dc69f45725dbacac4cb94ce
Upcoming events on Embla Medical hf.
Past events on Embla Medical hf.
| 23/04/2024 08:00 | Q1 2024 Earnings Call |
| 23/04/2024 06:00 | Q1 2024 Earnings Release |
| 13/03/2024 09:00 | Annual General Meeting |
| 30/01/2024 08:00 | Q4 2023 Earnings Call |
| 30/01/2024 07:00 | Q4 2023 Earnings Release |
| 16/01/2024 10:00 | Acquisition of Fior & Gentz by Össur hf Call |
| 07/01/2024 | SEB Nordic Seminar |
| 29/11/2023 | Danske Bank Winter Seminar |
| 24/10/2023 08:00 | Q3 2023 Earnings Call |
| 24/10/2023 05:00 | Q3 2023 Earnings Release |
| 05/09/2023 | Goldman Sachs European Medtech Conference |
| 23/08/2023 | Nordea Small & Mid Cap Days |
| 25/07/2023 08:00 | Q2 2023 Earnings Call |
| 25/07/2023 07:00 | Q2 2023 Earnings Release |
| 25/04/2023 08:00 | Q1 2023 Earnings Call |
| 25/04/2023 07:00 | Q1 2023 Earnings Release |
| 30/03/2023 07:00 | Capital Markets Day |
| 13/03/2023 | Carnegie Nordic Health Care Seminar |
| 10/03/2023 09:00 | Annual General Meeting |
| 08/03/2023 13:45 | ABGSC Investor Days |
Past dividends on Embla Medical hf.
| 12/03/2020 | Annual 0.15 DKK |
| 07/03/2019 | Annual 0.14 DKK |
| 08/03/2018 | Annual 0.13 DKK |
| 09/03/2017 | Annual 0.12 DKK |
| 10/03/2016 | Annual 0.12 DKK |
| 12/03/2015 | 0.12 DKK |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 686 686 -0.01% | 630 634 -0.71% | 719 721 -0.26% | 719 721 -0.37% | 786 783 0.35% | 869 |
|
EBITDA Million USD | Released Forecast Spread | 150 143 4.83% | 93,0 105 -11.85% | 149 151 -1.42% | 128 125 2.81% | 139 143 -2.73% | 165 |
|
EBIT Million USD | Released Forecast Spread | 106 101 5.08% | 28,3 46,5 -39.14% | 97,3 102 -4.46% | 78,8 75,1 4.95% | 89,4 93,1 -3.99% | 112 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 90,3 92,2 -2.1% | 12,7 35,3 -63.96% | 86,6 91,1 -4.9% | 56,2 61,2 -8.16% | 76,0 75,5 0.7% | 94,9 |
|
Net income Million USD | Released Forecast Spread | 66,0 70,7 -6.64% | 6,21 24,8 -74.91% | 64,0 66,3 -3.41% | 42,5 46,0 -7.59% | 58,4 57,3 1.88% | 72,2 |
|
EPS DKK | Released Forecast Spread | 1,09 1,11 -1.28% | 0,12 0,35 -66.85% | 1,03 1,06 -2.66% | 0,71 0,85 -16.85% | 0,97 0,98 -1.69% | 1,23 |
| Announcement Date | 04/02/20 | 02/02/21 | 01/02/22 | 31/01/23 | 30/01/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 170 174 -2.45% | 181 193 -6.46% | 177 184 -3.91% | 191 193 -1.11% | 181 183 -0.73% | 201 200 0.91% | 193 196 -1.37% | 210 211 -0.43% | 200 198 1.04% | 223 | 212 | 232 | |
|
EBITDA Million USD | Released Forecast Spread | 27,0 30,9 -12.67% | 32,9 42,0 -21.69% | 35,0 35,2 -0.5% | 33,6 36,5 -7.91% | 28,2 29,9 -5.62% | 37,4 38,6 -3.1% | 36,0 35,4 1.6% | 37,0 42,5 -12.84% | 33,0 32,7 0.92% | 44,9 | 40,3 | 50,3 | |
|
EBIT Million USD | Released Forecast Spread | 14,0 18,4 -23.89% | 20,5 28,7 -28.61% | 23,0 23,2 -0.68% | 21,2 23,6 -10.17% | 15,7 17,2 -8.54% | 25,0 25,2 -0.7% | 24,0 22,9 4.93% | 24,6 29,7 -16.93% | 15,4 19,5 -20.79% | 31,1 | 26,6 | 38,3 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 12,3 17,2 -28.26% | 19,1 26,4 -27.8% | 8,61 20,7 -58.35% | 16,2 20,3 -20.2% | 13,3 14,0 -5.3% | 20,6 21,4 -3.85% | 18,0 19,3 -6.55% | 24,2 23,5 2.85% | 11,0 15,7 -30.04% | 26,8 | 21,9 | 34,3 | |
|
Net income Million USD | Released Forecast Spread | -11,0 | 9,00 13,5 -33.33% | 14,1 20,5 -31.34% | 6,76 15,9 -57.39% | 12,9 15,7 -17.96% | 9,72 10,8 -9.95% | 15,8 17,0 -7.16% | 13,9 14,5 -4.18% | 19,0 19,0 0.23% | 8,00 13,0 -38.22% | 20,4 | 17,0 | 24,8 |
|
EPS DKK | Released Forecast Spread | 0,15 0,19 -19.98% | 0,25 0,35 -28.42% | 0,12 0,26 -54.48% | 0,21 0,26 -21.86% | 0,16 0,16 -0.01% | 0,26 0,27 -6.69% | 0,23 0,16 42.54% | 0,31 0,30 1.78% | 0,13 0,20 -32.16% | 0,33 | 0,28 | 0,41 | |
| Announcement Date | 23/07/20 | 26/04/22 | 21/07/22 | 25/10/22 | 31/01/23 | 25/04/23 | 25/07/23 | 24/10/23 | 30/01/24 | 23/04/24 | - | - | - |
| 30/04/2024 06:00 | STRAUMANN HOLDING AG: Q1 2024 Earnings Release |
| 05/05/2024 | DEMANT A/S: Q1 2024 Sales and Revenue Release - Interim Management Statement |
| 14/05/2024 06:00 | SONOVA HOLDING AG: Q4 2024 Earnings Release |
| 23/07/2024 06:00 | EMBLA MEDICAL HF.: Q2 2024 Earnings Release |
| 13/08/2024 | STRAUMANN HOLDING AG: Q2 2024 Earnings Release |
| 13/08/2024 | DEMANT A/S: Q2 2024 Earnings Release |
| 14/08/2024 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q2 2024 Earnings Release (Projected) |
| 14/08/2024 | COCHLEAR LIMITED: Q4 2024 Earnings Release |
| 21/08/2024 | ANGELALIGN TECHNOLOGY INC.: Q2 2024 Earnings Release (Projected) |
| 22/10/2024 06:00 | EMBLA MEDICAL HF.: Q3 2024 Earnings Release |
Past sector events for Embla Medical hf.
| 23/04/2024 06:00 | EMBLA MEDICAL HF.: Q1 2024 Earnings Release |
| 17/04/2024 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q1 2024 Earnings Release |
| 17/04/2024 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q4 2023 Earnings Release |
| 18/03/2024 | ANGELALIGN TECHNOLOGY INC.: Q4 2023 Earnings Release |
| 27/02/2024 06:00 | STRAUMANN HOLDING AG: Q4 2023 Earnings Release |
| 18/02/2024 20:30 | COCHLEAR LIMITED: Q2 2024 Earnings Release |
| 05/02/2024 16:45 | DEMANT A/S: Q4 2023 Earnings Release |
| 30/01/2024 07:00 | EMBLA MEDICAL HF.: Q4 2023 Earnings Release |
| 21/11/2023 06:00 | SONOVA HOLDING AG: Q2 2024 Earnings Release |
| 06/11/2023 | DEMANT A/S: Q3 2023 Sales and Revenue Release - Interim Management Statement |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EMBLA Stock
- Calendar Embla Medical hf.
